Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225506 · ClinicalTrials.gov registry record · NA

Support + High Intensity Functional Training for Parkinson's

A NA study, sponsored by Arkansas Colleges of Health Education.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT05225506: Completed NA study, sponsored by Arkansas Colleges of Health Education.

NCT05225506 is a NA study that has completed, run by Arkansas Colleges of Health Education. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05225506, a NA study, has completed, sponsored by Arkansas Colleges of Health Education.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Parkinson's is the fastest growing neurological disorder in the world. With more people living with Parkinson's than ever before, there is an urgent need for interventions that improve health and reduce disability. High intensity exercise has shown to be superior to other forms of exercise in that it can slow symptom progression. High intensity exercise also reduces the risk of cardiovascular events. This is pertinent considering one in five people with Parkinson's will die from cardiovascular disease. While Parkinson's specific exercise programs across the U.S. continue to increase, there are still many communities with limited to no access, including Fort Smith, Arkansas. Here, there are no expert level centers within 100 miles and not a single community-based exercise program. This research will offer a community and group-based exercise program for participants with Parkinson's and their care partners.

Primary Outcome

The percentage of interventions sessions attended by participants.

Interventions

  • BEHAVIORAL Exercise

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-02-21
Est. Completion 2022-11-24
Phase NA

What the finished NCT05225506 record still lists

NCT05225506 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.

NCT05225506 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05225506 about?

NCT05225506 is a clinical study titled "Support + High Intensity Functional Training for Parkinson's". Parkinson's is the fastest growing neurological disorder in the world. With more people living with Parkinson's than ever before, there is an urgent need for interventions that improve health and reduce disability. High intensity exercise has shown to be superior to other forms of exercise in that i...

What is the current status of trial NCT05225506?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-02-21. Estimated completion is 2022-11-24.

What interventions are being tested in trial NCT05225506?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05225506?

This trial is sponsored by Arkansas Colleges of Health Education, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05225506's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05225506, the US trial registry maintained by the National Library of Medicine. NCT05225506 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.